free html templates

Medicinal chemistry for start-ups

Address:

30 Victoria Rd
Burlingame, CA 94010

Phone:

1-650-787-8126

E-mail:

andrei@konradimolecular.com

Services

Drug discovery project evaluation, planning, and execution

Optimization of bioactive small molecules into drug candidates

Organic synthesis methods development

Execution of laboratory work at CROs in North America, Asia, and Europe

Composition of patent applications in collaboration with counsel

Principal

Andrei W. Konradi has twenty-five years of drug discovery research experience, and he has co-invented seven drug candidates that have been tested in humans.  Andrei has a BS in chemistry from MIT and a PhD in organic chemistry from Berkeley.

Partner CROs

Konradi Molecular collaborates with Partner CROs to execute projects for clients.  Konradi Molecular does not receive payments from Partner CROs

Published patent applications

Oxadiazole Compounds - Vivace Therapeutics

WO2019222431A1

Benzocarbonyl Compounds - Vivace Therapeutics

WO2019113236A1

Benzosulfonyl Compounds - Vivace Therapeutics

WO2019040380A1

Aminopyridine Compounds - Cortexyme

WO2018209132A1

Non-fused Tricyclic Compounds - Vivace Therapeutics

WO2018204532A1

Ketone Inhibitors of Lysine Gingipain - Cortexyme

WO2018053353A1

Antibacterial Agents - Achaogen

WO2017223349A1

Prodrugs of Phenolic TRPV1 Agonists - Concentric Analgesics

WO2017147146A1

Inhibitors or Arginine Gingipain - Cortexyme

WO2017083433A1

Tricyclic Compounds - Vivace Therapeutics

WO2017058716A1

Inhibitors of Lysine Gingipain - Cortexyme

WO2016057413A2

Methods for Conjugating Activatable Antibodies - CytomX

WO2014197612A1

© Copyright 2019 Konradi Molecular - All Rights Reserved